News Sentiment

CYP sentiment intelligence

Cynata Therapeutics Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 21 relevant articles
Exchange ASX Australia
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.01 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

85/100 classification confidence.

Company focus 21

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.0% over one week, -95.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Price to earnings forward of Cynata Therapeutics Limited – ASX:CYP

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 85/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive -95.0% over four weeks
Fair value -93.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 14
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 21
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Kalkine 6
Stocks Down Under 3
The Australian 2
simplywall.st 2
BioInformant 2
TradingView 1
BioWorld News 1
Sharecafe 1

Event Lens

What the news is about

Classified themes
Market update 15
Earnings 4
Regulatory and legal 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-21 of 21